Neurological medicine is advancing faster today than at any point in history—and at Brain Health Institute, we make sure our patients benefit from that progress. Dr. Deena Kuruvilla has dedicated her career to staying at the forefront of the field, conducting peer-reviewed research, participating in clinical trials, and speaking at national conferences. That commitment translates directly into patient care: when new, evidence-based treatments emerge, our patients are among the first to have access to them.
Recent years have brought remarkable breakthroughs in headache and neurological care. New classes of medications, such as CGRP-targeted therapies, have transformed migraine prevention and acute treatment. Neuromodulation devices—an area in which Dr. Kuruvilla has personally conducted published clinical research—offer drug-free options that use gentle electrical or magnetic stimulation to calm overactive pain pathways. Combined with advances in interventional procedures and integrative medicine, these innovations mean patients today have more effective options than ever before, including many who were previously told nothing more could be done.
What distinguishes our approach is discernment. Not every new treatment lives up to its promise, and the line between genuine innovation and passing trend is not always obvious. Dr. Kuruvilla carefully evaluates emerging therapies against the scientific evidence, recommending only those that are safe, effective, and appropriate for your specific condition. Through our involvement in clinical trials, qualifying patients may also gain access to promising treatments still in development. If you've tried standard treatments without success—or simply want to know what the latest science can offer you—we invite you to schedule a consultation and discover what's possible.
